1.An incision made at the areola mammae and pressure closure of residual cavity technology in benign breast lump removal
Yanming WANG ; Wei LI ; Cunfang KANG ; Kemin XIANG ; Lengjun YANG
Chongqing Medicine 2013;(33):4046-4047,4050
Objective To determine the clinical value of an incision made at the areola mammae and pressure closure of residual cavity technology applied to remove benign breast lumps .Methods 2 264 patients from January 2006 to May 2012 were performed using an incision made at the areola mammae for removing benign breast lumps and a pressure bandage to close the residual cavity in our department .The therapeutic results were evaluated through follow-up .Results All the benign breast lumps were resected safely and completely .The diameter of the single lump was 0 .5-8 .0 cm and the number of lesions was 1-42 .The mean operative time was 37 min(5-162 min) .There was minimum scar formation on breast ,the outline of the breast was maintained ,the rate of generating gelosis was 25 .4% ,the mean time of developing gelosis was 29 days(18 -40 days) ,and the rate of satisfaction was 98 .4% .No sever complications were found .Conclusion The technique in which an incision made at the areola mammae and pres-sure closure of residual cavity technology was applied to remove benign breast lumps is single ,safe and feasible surgical procedure with cosmetic results in clinical application .
2.The success rate of ventilator weaning in acute exacerbation of chronic obstructive pulmonary disease patients influenced by bobbed endotracheal intubation
Hui ZHANG ; Xueping ZHANG ; Yuchang ZHANG ; Cunfang BAN ; Binghua WANG
Chinese Journal of Postgraduates of Medicine 2016;39(10):938-940
Objective To study the success rate of ventilator weaning in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients influenced by bobbed endotracheal intubation. Methods One hundred and sixteen AECOPD patients who were given invasive mechanical ventilation and reached the standards of off-ventilator were divided into control group (general endotracheal intubation group) and experiment group bobbed (tracheal intubation) by random digits table method with 58 cases each. The respiratory rate (RR), heart rate (HR), rapid and shallow breathing index (RSBI), oxygenation index (OI), pulse blood oxygen saturation (SpO2), tidal volume and success rate of ventilator weaning were compared. Both groups were implemented of extubation if they reached the standards of the extubation time by observing their ability in spontaneous breathing test (SBT). Results The RR, HR and RSBI before extubation in experiment group were significantly lower than those in control group:(19.7 ± 2.3) times/min vs. (23.5 ± 2.3) times/min, (91.2 ± 6.3) times/min vs. (93.4 ± 8.1) times/min and 80.2 ± 6.7 vs. 90.5 ± 9.6, P<0.05, and the OI, SpO2, tidal volume and success rate of ventilator weaning were significantly higher than those in control group: (269 ± 9) mmHg (1 mmHg = 0.133 kPa) vs. (245 ± 16) mmHg, 0.929 ± 0.014 vs. 0.870 ± 0.037, (6.1 ± 1.2) ml/kg vs. (5.1 ± 0.8) ml/kg and 91.38%(53/58) vs. 77.59%(45/58), P<0.05. Conclusions The bobbed endotracheal intubations can improve the success rate of ventilator weaning in patients with AECOPD.
3.Effect of Ligustrazine on nNOS expression in different encephalic regions after focal cerebral ischemia in adult rats
Fen QIU ; Yong LIU ; Bo MA ; Cunfang QI ; Wenjing WANG
Journal of Xi'an Jiaotong University(Medical Sciences) 2004;0(05):-
0.05).In SVZ,nNOS expression in ischemic model group was reduced on days 1-14,but increased on day 21;after Ligustrazine administration,nNOS expression was obviously decreased on days 3-14 in all Ligustrazine dose groups,but began to increase on day 21.In CC,nNOS expression in ischemic model group was reduced on days 3-14,and began to increase on day 21;in the different-dose Ligustrazine groups,nNOS expression was significantly decreased on days 3-14,especially in medium-and high-dose groups,but increased on day 21.In striatum and cortex peri-infarction,nNOS expression in ischemic model group was obviously decreased on days 3 and 7,but enhanced on days 14 and 21;in various-dose Ligustrazine groups,nNOS expression was decreased on days 3-21,especially in medium-and high-dose groups,but increased slightly on day 21.In DG and CA1 areas,nNOS expression in ischemic model group was reduced on days 3 and 7,but began to increase on day 14;nNOS expression in all Ligustrazine groups were decreased during 3-21d.There were significant differences between ischemic model group and different-dose Ligustrazine groups at different time points(P
4.Effects of cerebroprotein hydrolysate for injection (II) on neuritogenesis and its underlying mechanisms
WEI Dasha ; GUAN Xin ; ZHANG Shengbin ; YU Fang ; WANG Cunfang ; ZHOU Yu ; PANG Tao
Journal of China Pharmaceutical University 2021;52(2):219-226
In most mammalian central nervous system diseases, axons are damaged.Due to the limited ability of damaged neurons to promote axonal regeneration, the formation of glial scar and the release of inhibitory nutrients, it is difficult to regenerate axons of damaged neurons. The purpose of this study was to investigate the effect of cerebroprotein hydrolysate for injection (II) (CBL) on neuritogenesis and its underlying mechanism. Immunofluorescence staining was used to detect the axon length of mouse neuroma cells (Neuro-2a) and mouse primary cortical neuronal cells. Western blotting was used to detect the expression of phosphorylated TrkB protein in Neuro-2a cells and mouse primary cortical neuronal cells. The results showed that CBL could increase the axon length of Neuro-2a cells or mouse primary cortical neuronal cells, and that the phosphorylation level of TrkB in neuronal cells was significantly increased when 5 μg/mL CBL was applied to neuronal cells for 1 h. In conclusion, CBL can promote neuritogenesis, and increase the expression of phosphorylated TrkB, which may be related to the activation of TrkB signaling pathway.
5.Drug resistance characteristics and epidemic trend of Escherichia coli in Anning, Yunnan
Cunfang LIU ; Yan WANG ; Rong YANG ; Lixiang HU
Journal of Public Health and Preventive Medicine 2020;31(4):58-61
Objective To investigate the drug resistance characteristics and epidemic trend of Escherichia coli in Anning, Yunnan, and to provide a reference for clinical rational use of antibiotics. Methods A total of 376 strains of Escherichia coli were isolated from June 2018 to June 2019 from Kungang Hospital of Yunnan Province. The ESBLs producing strains were screened by double disk method and the sensitivity of ESBLs to antibiotics was detected by K-B method. The genotyping of ESBLs strains and the class I, II and III integrase genes in integron 3' and 5' conservative regions was conducted using polymerase chain reaction (PCR). Results The detection rate of ESBLs producing Escherichia coli was 53.19% (200/376). ESBLs-producing Escherichia coli had a low resistance rate to carbapenem antibacterial drugs with a relatively high sensitivity. The resistance rates to amikacin and piperacillin were 7.50% and 12.50% respectively, which had good antibacterial activity. The resistance rate to other antibiotics was high. There were 74.00% (148/ 200) of ESBLs-producing Escherichia coli carrying CTX-M gene, 34.50% (69/200) carrying TEM genes, and 1.00% (2/200) of strains carrying SHV genes. In addition, there were 9.00% (18/200) of strains carrying both CTX-M and TEM genes, and 0.50% (1/200) of strains carrying both CTX-M and SHV genes. The detection rate of integrons accounted for 37.00% (74/200), all of which were class I integrons. Conclusion The prevalence of ESBLs-producing Escherichia coli was relatively high in Anning, Yunnan. ESBLs-producing Escherichia coli showed a trend of multi-drug resistance. The genotype was mainly CTX-M, and the integron was classified as class I.
6.A novel PGAM5 inhibitor LFHP-1c protects blood-brain barrier integrity in ischemic stroke.
Chenglong GAO ; Yazhou XU ; Zhuangzhuang LIANG ; Yunjie WANG ; Qinghong SHANG ; Shengbin ZHANG ; Cunfang WANG ; Mingmin NI ; Dalei WU ; Zhangjian HUANG ; Tao PANG
Acta Pharmaceutica Sinica B 2021;11(7):1867-1884
Blood-brain barrier (BBB) damage after ischemia significantly influences stroke outcome. Compound LFHP-1c was previously discovered with neuroprotective role in stroke model, but its mechanism of action on protection of BBB disruption after stroke remains unknown. Here, we show that LFHP-1c, as a direct PGAM5 inhibitor, prevented BBB disruption after transient middle cerebral artery occlusion (tMCAO) in rats. Mechanistically, LFHP-1c binding with endothelial PGAM5 not only inhibited the PGAM5 phosphatase activity, but also reduced the interaction of PGAM5 with NRF2, which facilitated nuclear translocation of NRF2 to prevent BBB disruption from ischemia. Furthermore, LFHP-1c administration by targeting PGAM5 shows a trend toward reduced infarct volume, brain edema and neurological deficits in nonhuman primate